Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Category: Pharma applications

April 17, 2023 CD as API / Uncategorized

Neostigmine vs. sugammadex: on postoperative nausea and vomiting (PONV) after general anaesthesia

Sugammadex (SGM) is the first cyclodextrin derivative approved as an API, the result of a rational drug design, with a

Continue reading

April 14, 2023 CD as API / CD derivatives / Pharma applications

Grafting of Cyclodextrin to Theranostic Nanoparticles Improves Blood-Brain Barrier Model Crossing

Core–shell superparamagnetic iron oxide nanoparticles hold great promise as a theranostic platform in biological systems. Herein, we report the biological

Continue reading

April 10, 2023 Drug delivery / Pharma applications

Inclusion complexation and liposomal encapsulation of an isoniazid hydrazone derivative in cyclodextrin for pH-dependent controlled release

Tuberculosis, a predominantly pulmonary pathology, is currently the deadliest infection worldwide. Its treatment is based on combination therapy involving selected

Continue reading

April 7, 2023 CD as API / Drug delivery / Pharma applications

Special Issue entitled “The Role of Carbohydrate in Pharmaceuticals, Vaccines and Delivery Systems”

Special Issue entitled “The Role of Carbohydrate in Pharmaceuticals, Vaccines and Delivery Systems”, inPharmaceutics (*IF 6.525, 5-Year IF 7.227, PubMed,

Continue reading

April 4, 2023 Drug delivery / Pharma applications

Antibacterial drugs and cyclodextrin inclusion complexes: a patent review

The patents analyzed in the review used treatments based on antibiotics already on the market, natural products, and synthesized molecules

Continue reading

March 31, 2023 Drug delivery / Pharma applications / Supramolecular systems

Nitric Oxide-Releasing Topological Supramolecular Nanocarriers with sliding CD units against MRSA

Polymeric systems that provide cationic charges or biocide-release therapeutics are used to treat the bacteria-infected wound. However, most antibacterial polymers

Continue reading

March 30, 2023 CD as API / Drug delivery / Pharma applications

Antimicrobial and Antibiofilm Photodynamic Action of Photosensitizing Nanoassemblies Based on Sulfobutylether-β-Cyclodextrin

Developing new broad-spectrum antimicrobial strategies, as alternatives to antibiotics and being able to efficiently inactivate pathogens without inducing resistance, is

Continue reading

March 29, 2023 Drug delivery / Pharma applications

Review on cyclodextrin encapsulation and inteligent response  for  the release of curcumin 

To overcome the low water solubility and low bioavailability of curcumin (CUR), multiple delivery strategies have been proposed. Among these,

Continue reading

March 27, 2023 Drug delivery / Pharma applications

Synergistic Antitumor Potency of a Self-Assembling Cyclodextrin Nanoplex for the Co-Delivery of 5-Fluorouracil and Interleukin-2 in the Treatment of Colorectal Cancer

Chemotherapy is the most used method after surgery in the treatment of colon cancer. Cancer cells escape the recognition mechanism

Continue reading

March 24, 2023 Drug delivery

Oculis goes public on the Nasdaq Stock Market

Oculis the Icelandic (now global) ophthalmology company, founded by Thorsteinn Loftsson and Einar Stefánsson, celebrated its public listing on the

Continue reading

Posts navigation

«Previous Posts 1 2 3 4 5 … 80 Next Posts»

Recent Posts

  • Antifungal pentachloronitrobenzene/hydroxypropyl-beta-cyclodextrin inclusion complex nanofibers by electrospinning with no polymer
  • Special issue of EuroCD2023 is open for submission
  • Ensembles of carboxymethyl cyclodextrins on cationic liposomes as highly efficient nanocontainers for the delivery of hydrophobic compounds
  • Exploring Isomerism in Isolated Cyclodextrin Oligomers through Trapped Ion Mobility Mass Spectrometry
  • Avoiding Interferences in Advance: Cyclodextrin Polymers to Enhance Selectivity in Extraction of Organic Micropollutants for Carbon Isotope Analysis

Tags

alpha-CD Alzheimer disease Biotechnology Cancer therapy Captisol Cholesterol Clinical trial conference coronavirus Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems FDA Food Gilead HPBCD Nanoparticles nanotechnology Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis wastewater treatment

Follow Us

  • LinkedIn
  • Twitter
  • Facebook

Categories

  • Agriculture (15)
  • Analysis (37)
  • CD as API (214)
  • CD derivatives (268)
  • Cosmetics and toilettry (22)
  • Diagnosis (1)
  • Drug delivery (458)
  • E-ducation (56)
  • Environmental (80)
  • Events (163)
  • Food (128)
  • Gene delivery (10)
  • In Hungarian (4)
  • Life sciences (19)
  • Non-pharma applications (228)
  • Other industrial use (68)
  • Pharma applications (727)
  • Supramolecular systems (27)
  • Uncategorized (47)

Top Posts

  • Special issue of EuroCD2023 is open for submission
  • Lanosterol eye drops for cataract treatment
  • Avoiding Interferences in Advance: Cyclodextrin Polymers to Enhance Selectivity in Extraction of Organic Micropollutants for Carbon Isotope Analysis
  • 7th European Cyclodextrin Conference
  • Ensembles of carboxymethyl cyclodextrins on cationic liposomes as highly efficient nanocontainers for the delivery of hydrophobic compounds
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies
  • Ashland webinar — the magic rings: how cyclodextrins can enable drug development
  • Antifungal pentachloronitrobenzene/hydroxypropyl-beta-cyclodextrin inclusion complex nanofibers by electrospinning with no polymer
  • Website of EuroCD Conference is open
  • Synthesis and potential applications of cyclodextrin-based metal–organic frameworks: a review

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 551 other subscribers
 

Loading Comments...